Global Pharmaceutical Firm AstraZeneca Gets Expansion Approval Posted on: July 5th, 2020 AstraZeneca – the global sciene-led biopharmaceutical business – has received the go-ahead for a new 8,890 sq m facility in Macclesfield. The site, on their Hurdsfield Campus, will see a new facility built that would house manufacturing, technical, storage and preparation areas for more than 72 employees. Cheshire East Council has given the thumbs up to the project, but remediation work will need to be completed on the site which has previously been used for waste disposal. AstraZeneca – who’re speaking on our upcoming Oxford Cambridge ARC Development Conference to discuss expansion plans at their UK HQ in Cambridge – worked closely with Baker Hicks on the project, a multi-disciplinary design and engineering company. Their report stated: “The construction of this building will ensure AstraZeneca maintain their position as a leading global biopharmaceutical business and marks a long-term commitment to continued manufacturing at the Macclesfield campus. In short, the proposed development will have a positive effect on economic growth in the area.” The plans however could take a few years to kickstart – as the applicant has requested 5 years to begin building rather than the usual three. Political uncertainty and Brexit were touted as potential issues which could create a more complex environment for investors.